9W4-17398-21619
3 vaccinations
1 coded response
22 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 895 / NV
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Dose 1 — Pfizer-BioNTech
-
2021-01-06
Registered in v-safe
- 2021-01-06
- 2021-01-07
- 2021-01-09
- 2021-01-16
-
2021-01-23
Dose 2 — Pfizer-BioNTech
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-28
- 2021-03-06
- 2021-04-24
- 2021-07-24
-
2022-01-17
Dose 3 — Pfizer-BioNTech
- 2022-01-23
- 2022-01-24
- 2022-01-31
- 2022-02-07
- 2022-02-14
- 2022-02-23
- 2022-02-28
- 2022-04-19
- 2022-07-20
-
2023-01-17
Survey response — 12 months, dose 3MedDRA: Chills, Cold sweat, Confusional state, Cough, Diarrhoea, Dizziness, Dyspnoea, Feeling cold, Hyperhidrosis, Lethargy, Malaise, Nausea, Pyrexia, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-01-17
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-01-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Pfizer-BioNTech | |
| 2 | 2021-01-23 | Pfizer-BioNTech | |
| 3 | 2022-01-17 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cold sweat | · | · | ✓ |
| SD | Confusional state | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Feeling cold | · | · | ✓ |
| SD | Hyperhidrosis | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release